Exploring an animal model of amodiaquine-induced liver injury in rats and mice

References

• Angelucci A, Festuccia C, Gravina GL, Muzi P, Bonghi L, Vicentini C, Bologna M. 2004. Osteopontin enhances cell proliferation induced by the epidermal growth factor in human prostate cancer cells. Prostate. 59:157–166.
   PubMed Web of Science ®Google Scholar
• Banissi C, Ghiringhelli F, Chen L, Carpentier AF. 2009. Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model. Cancer Immunol Immunother. 58:1627–1634.
   PubMed Web of Science ®Google Scholar
• Betten A, Dahlgren C, Mellqvist UH, Hermodsson S, Hellstrand K. 2004. Oxygen radical-induced natural killer cell dysfunction: Role of myeloperoxidase and regulation by serotonin. J Leukocyte Biol. 75:1111–1115.
   PubMed Web of Science ®Google Scholar
• Clarke JB, Maggs JL, Kitteringham NR, Park BK. 1990. Immunogenicity of amodiaquine in the rat. Int Arch Allergy Appl Immunol. 91:335–342.
   PubMedGoogle Scholar
• Clarke JB, Neftel K, Kitteringham NR, Park BK. 1991. Detection of anti-drug IgG antibodies in patients with adverse drug reactions to amodiaquine. Int Arch Allergy Appl Immunol. 95:369–375.
   PubMedGoogle Scholar
• Czaja MJ, Geerts A, Xu J, Schmiedeberg P, Ju Y. 1994. Monocyte chemoattractant protein (MCP)-1 expression occurs in toxic rat liver injury and human liver disease. J Leukocyte Biol. 55:120–126.
   PubMed Web of Science ®Google Scholar
• Diao H, Liu X, Wu Z, Kang L, Cui G, Morimoto J, Denhardt DT, Rittling S, Iwakura Y, Uede T, Li L. 2012. Osteopontin regulates IL-17 production in hepatitis. Cytokine. 60:129–137.
   PubMed Web of Science ®Google Scholar
• Dijkstra CD, Dopp EA, Joling P, Kraal G. 1985. The heterogeneity of mononuclear phagocytes in lymphoid organs: Distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2, and ED3. Immunology. 54:589–599.
   PubMed Web of Science ®Google Scholar
• Gignoux E, Azman AS, de Smet M, Azuma P, Massaquoi M, Job D, Tiffany A, Petrucci R, Sterk E, Potet J, et al. 2016. Effect of artesunate-amodiaquine on mortality related to Ebola virus disease. N Engl J Med. 374: 23–32.
   PubMed Web of Science ®Google Scholar
• Glick L. 1957. Fatal agranulocytosis during treatment with a amodiaquine. Br Med J. 1:932.
   PubMed Web of Science ®Google Scholar
• Guevart E, Aguemon A. 2009. Two cases of fulminant hepatitis during a curative treatment with an artesunate-amodiaquine combination. Med Mal Infect. 39:57–60.
   PubMed Web of Science ®Google Scholar
• Harrison AC, Kitteringham NR, Clarke JB, Park BK. 1992. The mechanism of bioactivation and antigen formation of amodiaquine in the rat. Biochem Pharmacol. 43:1421–1430.
   PubMed Web of Science ®Google Scholar
• Hirschel B. 2003. Questions about the antimalarial amodiaquine. Lancet. 361:2.
   Google Scholar
• Kaplowitz N. 2001. Drug-induced liver disorders: Implications for drug development and regulation. Drug Safety. 24:483–490.
   PubMed Web of Science ®Google Scholar
• Lee WM. 2003. Drug-induced hepatotoxicity. N Engl J Med. 349:474–485.
   PubMed Web of Science ®Google Scholar
• Lee YS, Jeong WI. 2012. Retinoic acids and hepatic stellate cells in liver disease. J Gastroenterol Hepatol. 27:75–79.
   PubMed Web of Science ®Google Scholar
• Lind DE, Levi JA, Vincent PC. 1973. Amodiaquine-induced agranulocytosis: Toxic effect of amodiaquine in bone marrow cultures in vitro. Br Med J. 1:458–460.
   PubMed Web of Science ®Google Scholar
• Liu YJ, Zhang DQ, Sui XM, Tian W. 2009. Overexpression of human osteopontin increases cell proliferation and migration in human embryo kidney-293 cells. Cell Mol Biol Lett. 14:670–678.
   PubMed Web of Science ®Google Scholar
• Lobach AR, Uetrecht J. 2014. Involvement of myeloperoxidase and nadph oxidase in the covalent binding of amodiaquine and clozapine to neutrophils: implications for drug-induced agranulocytosis. Chem Res Toxicol. 27:699–709.
   PubMed Web of Science ®Google Scholar
• Mandrekar P, Ambade A, Lim A, Szabo G, Catalano D. 2011. An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: Regulation of pro-inflammatory cytokines and hepatic steatosis in mice. Hepatology. 54:2185–2197.
   PubMed Web of Science ®Google Scholar
• Masson MJ, Carpenter LD, Graf ML, Pohl LR. 2008. Pathogenic role of natural killer T and natural killer cells in acetaminophen-induced liver injury in mice is dependent on the presence of dimethyl sulfoxide. Hepatology. 48:889–897.
   PubMed Web of Science ®Google Scholar
• Metushi IG, Zhu X, Chen X., Gardam MA, Uetrecht J. 2014. Mild isoniazid-induced liver injury in humans is associated with an increase in TH17 cells and T-cells producing IL-10. Chem Res Toxicol. 27:683–689.
   PubMed Web of Science ®Google Scholar
• Metushi IG, Cai P, Dervovic D, Liu F, Lobach A, Nakagawa T, Uetrecht J. 2015a. Development of a novel mouse model of amodiaquine-induced liver injury with a delayed onset. J Immunotoxicol. 12:247–260.
   PubMed Web of Science ®Google Scholar
• Metushi IG, Hayes MA, Uetrecht J. 2015b. Treatment of PD-1 mice with amodiaquine and anti-CTLA4 leads to liver injury similar to idiosyncratic liver injury in patients. Hepatology. 61:1332–1342.
   PubMed Web of Science ®Google Scholar
• Millman AC, Salman M, Dayaram YK, Connell ND, Venketaraman V. 2008. Natural killer cells, glutathione, cytokines, and innate immunity against Mycobacterium tuberculosis. J Interferon Cytokine Res. 28:153–165.
   PubMed Web of Science ®Google Scholar
• Mizutani T, Irie Y, Nakanishi K. 1994. Styrene-induced hepatotoxicity in mice depleted of glutathione. Res Commun Mol Pathol Pharmacol. 86:361–374.
   PubMed Web of Science ®Google Scholar
• Mizutani T, Murakami M, Shirai M, Tanaka M, Nakanishi K. 1999. Metabolism-dependent hepatotoxicity of methimazole in mice depleted of glutathione. J Appl Toxicol. 19:193–198.
   PubMed Web of Science ®Google Scholar
• Mizutani T, Satoh K, Nomura H, Nakanishi K. 1991. Hepatotoxicity of eugenol in mice depleted of glutathione by treatment with DL-buthionine sulfoximine. Res Commun Chem Pathol Pharmacol. 71:219–230.
   PubMedGoogle Scholar
• Nakagawa K, Miller FN, Sims DE, Lentsch AB, Miyazaki M, Edwards MJ. 1996. Mechanisms of IL-2-induced hepatic toxicity. Cancer Res. 56:507–510.
   PubMed Web of Science ®Google Scholar
• Papadakis KA, Prehn JL, Landers C, Han Q, Luo X, Cha SC, Wei P, Targan SR. 2004. TL1A synergizes with IL-12 and IL-18 to enhance IFNγ production in human T-cells and NK cells. J Immunol. 172:7002–7007.
   PubMed Web of Science ®Google Scholar
• Peraldi MN, Berrou J, Dulphy N, Seidowsky A, Haas P, Boissel N, Metivier F, Randoux C, Kossari N, Guérin A, et al. 2009. Oxidative stress mediates a reduced expression of the activating receptor NKG2D in NK cells from end-stage renal disease patients. J Immunol. 182:1696–1705.
   PubMed Web of Science ®Google Scholar
• Ramaiah SK, Rittling S. 2007. Role of osteopontin in regulating hepatic inflammatory responses and toxic liver injury. Expert Opin Drug Metab Toxicol. 3:519–526.
   PubMed Web of Science ®Google Scholar
• Shimizu S, Atsumi R, Itokawa K, Iwasaki M, Aoki T, Ono C, Izumi T, Sudo K, Okazaki O. 2009. Metabolism-dependent hepatotoxicity of amodiaquine in glutathione-depleted mice. Arch Toxicol. 83:701–707.
   PubMed Web of Science ®Google Scholar
• Taimr P, Higuchi H, Kocova E, Rippe RA, Friedman S, Gores GJ. 2003. Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis. Hepatology. 37:87–95.
   PubMed Web of Science ®Google Scholar
• Taylor WR, White NJ. 2004. Anti-malarial drug toxicity: A review. Drug Safety. 27:25–61.
   PubMed Web of Science ®Google Scholar
• Trinchieri G. 2003. IL-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol. 3:133–146.
   PubMed Web of Science ®Google Scholar
• Uetrecht J. 2005. Role of animal models in the study of drug-induced hypersensitivity reactions. AAPS J. 7:E914–E921.
   Web of Science ®Google Scholar
• Uetrecht J. 2008. Idiosyncratic drug reactions: Past, present, and future. Chem Res Toxicol. 21:84–92.
   PubMed Web of Science ®Google Scholar
• Viora M, Quaranta MG, Straface E, Vari R, Masella R, Malorni W. 2001. Redox imbalance and immune functions: opposite effects of oxidized low-density lipoproteins and N-acetylcysteine. Immunology. 104:431–438.
   PubMed Web of Science ®Google Scholar
• White NJ, Looareesuwan S, Edwards G, Phillips RE, Karbwang J, Nicholl DD, Bunch C, Warrell DA. 1987. Pharmacokinetics of intravenous amodiaquine. Br J Clin Pharmacol. 23:127–135.
   PubMed Web of Science ®Google Scholar